FDA Investigator Peter Abel

Peter Abel has conducted inspections on 80 sites in 8 countries as of 17 Nov 2003. See below for a list of the FDA enforcement documents resulting from those inspections.

Investigator Details

Number of Inspected Sites:
80
Last Inspection Date:
17 Nov 2003
Investigator Role:
FDA Investigator
Redica ID:
Countries of Inspections:
United Kingdom of Great Britain and Northern Ireland, United States of America, France, Sweden, Malaysia, Germany, Switzerland, Indonesia
FDA Investigators that have inspected at least one site in common with Peter Abel:
Alia Legaux, Alice S Tsao, Althea A Williams, Amatul H Marium, Amy Wyan Mai, Andrew F Cohen, Andrew J Garufi, Andrew M Abramowitz, Arduino Frankovic, Arthur G Hurst, Arthur S Williams, Jr, Barbara Janine Breithaupt, Bijoy Panicker, Brandon L Mariner, Burnell M Henry, Charanjeet Jassal, Charisse K Green, Charles L Larson, Christian Parra, Christine M Rivera, Christopher S Fields, Daniel J Lahar, Daniel L Aisen, Daniel L Zheng, Dave M Deroche, David R Delucia, Deborah A Greco, Demitria J Xiradakis, Dennis E Guilfoyle, PhD, Devon O Seymour, Dipesh K Shah, Donald G Gordon, Dongping Dai, PhD, Donna Ltartaglino Besone, Dorothy W Lee, Douglas G Ng, Dr. Gang Wang, PhD, Dr. Robert C Horan, MD, Edmund F Mrak, Jr, Elizabeth B Griffin, Elizabeth D Connell, Esteban Beltran, Evelyn Taha, Felix Maldonado, Francis J Eng, Frank Verni, Gam S Zamil, Gary J Lehr, Gary T Greco, Gene D Arcy, Gloria E Parra, Gregson A Joseph, Haydee B Romero, Helen B Ricalde, Ilana Zigelman, Iram R Hassan, PhD, Irina Gaberman, Jacqueline Mdiaz Albertini, Jacqueline S Warner, Jagdish R Amin, James A Liubicich, Jason D Tenney, Jay T Wong, John A Podsadowski, John A Sciacchitano, Jose Ohernandez Guzman, Joseph Maselli, Joy P Matthias, Juanita P Versace, Judy Friedman, Julie D Bringger, Karen L Kosar, Karishma G Gopaul, Kenneth H Williams, Kent C Hermann, Kevin A Gonzalez, Kim Lthomas Cruse, Kim M Downing, Kimberley A Ricketts, Kwong P Lee, L Gnnmassimia Massimilla, PharmD, Laura M Howard, Laura Schankweiler, Lawrence W Farina, Leena Thomas, Lisa Mathew, LT Colin E Tack, BSE, LTJG Matthew R Palo, Marc S Neubauer, Margaret M Annes, Marie B Buen Bigornia, Matthew A Spataro, Matthew D Schnittker, Mercy O Quagraine, Meredith P Soehl, Investigator, Michael A Charles, Michael G Mayfield, Michael R Dominick, Michael W Burd, Mindy M Chou, Mohammad Heidaran, PhD, Nariman Patenaude, Nazmul Hassan, Neil J Bonzagni, PhD MPH, Nicholas A Violand, Nicholas C Mendiola, Parul M Patel, Patricia A Clark, Patricia A Mcilroy, Paul E Stein, Paul Mouris, Paul P Geraci, Paula A Trost, Perry H Gambrell, Peter Caparelli, Peter R Caparelli, Prabhu P Raju, Preston M Lee, Rachael A Moliver, Raihan A Chowdhury, Ramon A Hernandez, Rebecca Rodriguez, Richard Ferfoglia, Robert C Steyert, Rochelle K Kimmel, Rodney D Combs, Ronald Ifraimov, Ronald T Weber, Rosanna M Goodrich, Russ E Davis, Samina S Khan, Samuel A Francis, Samuel Eskenazi, Samuel T Walker, Sarah A Meehan, Sarah A Wangseng, Satheesh Thomas, Shari L Kahn, Sony Mathews, Stephanie T Durso, Sunita Vij, Susan T Hadman, Tara K Carmody, Thomas J Arista, Thomas J Mccrey, Thomas J Mooney, Thomas P Hansen, Uduak M Inokon, Valerie A Potopsingh, Valerie Jgrecek Trinh, Victor Spanioli, Wayne S Fortenberry

Peter Abel's Documents

Publish Date Document Type Title
June, 2003 EIR Phadia Ab - EIR, 2003-06-19
April, 2000 EIR Ortho-Clinical Diagnostics - EIR, 2000-04-12
August, 2000 FDA 483 New York Blood Center, Inc. - Form 483, 2000-08-22
September, 2001 EIR Advance Pharmaceutical, Inc. - EIR, 2001-09-06
March, 2001 EIR Ortho Clinical Diagnostics - EIR, 2001-03-26
November, 2001 FDA 483 Pfizer, Inc. - Form 483, 2001-11-30
October, 2000 EIR American Regent, Inc. - EIR, 2000-10-12
June, 2000 FDA 483 Fougera Pharmaceuticals Inc. - Form 483, 2000-06-29
March, 2002 FDA 483 Chartwell Pharmaceuticals Amityville, LLC. - Form 483, 2002-03-13
November, 2003 EIR DePuy AcroMed SARL - EIR, 2003-11-13
June, 2003 FDA 483 Response Phadia Ab - Form 483R, 2003-07-01
November, 2000 FDA 483 Chembio Diagnostic Systems, Inc - Form 483, 2000-11-15
April, 2000 FDA 483 Ortho Clinical Diagnostics - Form 483, 2000-04-14
August, 2000 EIR New York Blood Center, Inc. - EIR, 2000-08-22
August, 2000 FDA 483 Response New York Blood Center, Inc. - Form 483R, 2000-11-16
March, 2002 FDA 483 Response Chartwell Pharmaceuticals Amityville, LLC. - Form 483R, 2002-03-26
April, 2000 EIR Ortho-Clinical Diagnostics - EIR, 2000-05-03
May, 2000 FDA 483 Response Hemocare Product Center - Form 483R, 2000-05-23
June, 2003 FDA 483 Phadia Ab - Form 483, 2003-06-19
August, 2002 FDA 483 Response Fougera Pharmaceuticals Inc. - Form 483R, 2002-08-19
August, 2002 FDA 483 Fougera Pharmaceuticals Inc. - Form 483, 2002-08-07
May, 2000 FDA 483 Mediware Information Systems, Inc. - Form 483, 2000-05-16
June, 2000 EIR Fougera Pharmaceuticals Inc. - EIR, 2000-06-29
August, 2002 FDA 483 Fougera Pharmaceuticals Inc. - Form 483, 2002-08-07
June, 2000 FDA 483 Response Fougera Pharmaceuticals Inc. - Form 483R, 2000-07-24
September, 2001 EIR PDK Labs, Inc - EIR, 2001-09-13
August, 2002 EIR Fougera Pharmaceuticals Inc. - EIR, 2002-08-07
March, 2002 EIR Chartwell Pharmaceuticals Amityville, LLC. - EIR, 2002-03-13
November, 2000 FDA 483 Response Chembio Diagnostic Systems, Inc - Form 483R, 2000-12-05

Experience Redica Systems’ NEW investigator profiles and dashboards

Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:

  • Total inspections conducted
  • 483 rate
  • OAI rate
  • Warning Letter rate
  • Inspections by Industry, Scope, and Inspection Reason
  • And much more

Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.

FDA Investigator Profile Icon

Talk to sales to access our investigator profiles

Loading...

Investigator Profiles Are Just the Tip of the Iceberg

Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:

Inspection Intelligence

  • Pre-Approval Inspection (PAI) trends
  • The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
  • Latest 483s: see what the trends are across all FDA Investigators
  • CFR Heatmap: Citations aggregated by Subpart by Year

Vendor Intelligence

  • Full inspection histories for your vendors down to the specific site level
  • All of the functionality mentioned above but isolated to just your vendors

Regulatory Intelligence

  • Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
  • All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more